Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Infant visual acuity

This article was originally published in The Tan Sheet

Executive Summary

Infants fed formula containing docosahexaenoic acid (DHA) and arachidonic acid (AA) "showed acuity maturation similar to that of the human milk-fed group throughout the first year of life" in a study of 108 healthy term infants published in the August issue of Pediatric Research. The study, by Eileen Birch et al., concludes "early dietary intake of preformed DHA and AA appears necessary for optimal development of the brain and eye of the human infant." The DHA and AA were supplied by Columbia, Md.-based Martek. The company maintains the study "is the first to show a persistent effect in visual acuity development related to dietary intake of DHA." A grant from NIH funded the study while Mead Johnson provided the formula and supplementary funding...
Advertisement

Related Content

Similac Superiority Claims Over Enfamil Should Be Modified – NAD
Similac Superiority Claims Over Enfamil Should Be Modified – NAD
Similac Superiority Claims Over Enfamil Should Be Modified – NAD

Topics

Advertisement
UsernamePublicRestriction

Register

PS088760

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel